Knight Announces Closing of US$100 Million Revolving Credit Facility
MONTREAL, Oct. 31, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) ("Knight" or "the Company"), a pan-American (ex-US) specialty pharmaceutical company, announced today that it has closed the syndication of its US$100 million secured revolving cre
(Financial Post, 2025-10-31T21:18:31Z)